These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37852795)

  • 1.
    Ma J; Laskin OL; Roffel AF; Vaes WHJ; Tang B; Kolnaar J; O'Keefe K; Golden L; Kong R
    Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37852795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution, metabolism and excretion of
    Ma J; Ye Q; Northcutt V; Babiak J; Kong R
    Xenobiotica; 2022 Dec; 52(12):1031-1040. PubMed ID: 36700425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitor.
    Ma J; Kaushik D; Yeh S; Northcutt V; Babiak J; Risher N; Weetall M; Moon YC; Welch EM; Molony L; O'Keefe K; Kong R
    Xenobiotica; 2022 Feb; 52(2):152-164. PubMed ID: 34846990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects.
    Holmberg AA; Weidolf L; Necander S; Bold P; Sidhu S; Pelay-Gimeno M; de Ligt RAF; Verheij ER; Jauhiainen A; Psallidas I; Wählby Hamrén U; Prothon S
    Drug Metab Dispos; 2022 Feb; 50(2):150-157. PubMed ID: 34853068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans.
    Bhattacharya C; Sandinge AS; Bragg RA; Heijer M; Yan J; Andersson LC; Jurva U; Pelay-Gimeno M; Vaes WHJ; de Ligt RAF; Gränfors M; Amilon C; Lindstedt EL; Menakuru SR; Garkaviy P; Weidolf L; Gopaul VS
    Drug Metab Dispos; 2023 Apr; 51(4):451-463. PubMed ID: 36639243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor.
    Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Bar CM; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R
    Eur J Clin Pharmacol; 2023 Aug; 79(8):1073-1080. PubMed ID: 37278823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling.
    Wen B; Zhang Y; Young GC; Kenworthy D; Pereira A; Pirhalla J; Doyle J; Jordon B; Zhan J; Johnson M
    Drug Metab Dispos; 2022 Nov; 50(11):1442-1453. PubMed ID: 36153007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.
    Martin P; Oliver S; Kennedy SJ; Partridge E; Hutchison M; Clarke D; Giles P
    Clin Ther; 2012 Jan; 34(1):221-37. PubMed ID: 22206795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.
    Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R
    Pharmacol Res Perspect; 2023 Apr; 11(2):e01076. PubMed ID: 36938928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, absorption, metabolism, and excretion of [
    Prakash C; Fan B; Altaf S; Agresta S; Liu H; Yang H
    Cancer Chemother Pharmacol; 2019 May; 83(5):837-848. PubMed ID: 30758648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
    Lindmark B; Li XQ; Bhattacharya C; Housler G; Heijer M; Bragg RA; Gränfors M; Pelay-Gimeno M; Vaes WHJ; Menakuru S; Pizzato PE; Ericsson H; Johansson S
    Drug Metab Dispos; 2023 Aug; 51(8):995-1004. PubMed ID: 37407094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism, excretion and pharmacokinetics of [
    Lam JL; Vaz A; Hee B; Liang Y; Yang X; Shaik MN
    Xenobiotica; 2017 Dec; 47(12):1064-1076. PubMed ID: 27866461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.
    Pérez LY; Menéndez R; Más R; González RM
    Curr Ther Res Clin Exp; 2006 Nov; 67(6):406-19. PubMed ID: 24678113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, Excretion, and Mass Balance of [
    Ambery C; Young G; Fuller T; Lazaar AL; Pereira A; Hughes A; Ramsay D; van den Berg F; Daley-Yates P
    Clin Pharmacol Drug Dev; 2018 Nov; 7(8):901-910. PubMed ID: 30230263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.
    Chen L; Sabo JP; Philip E; Mao Y; Norris SH; MacGregor TR; Wruck JM; Garfinkel S; Castles M; Brinkman A; Valdez H
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2436-44. PubMed ID: 17485497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor.
    Takahashi RH; Malhi V; Liederer BM; Cho S; Deng Y; Dean B; Nugteren J; Yost E; Al-Sayah MA; Sane R; Kshirsagar S; Ma S; Musib L
    Drug Metab Dispos; 2023 Oct; 51(10):1332-1341. PubMed ID: 37524543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, metabolism, excretion, and safety of [
    Zhou C; Xie L; Liu W; Zhang L; Zhou S; Wang L; Chen J; Li H; Zhao Y; Zhu B; Ding S; Zhang C; Shao F
    Ann Transl Med; 2021 May; 9(10):867. PubMed ID: 34164501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia.
    Branstrom A; Cao L; Furia B; Trotta C; Santaguida M; Graci JD; Colacino JM; Ray B; Li W; Sheedy J; Mollin A; Yeh S; Kong R; Sheridan R; Baird JD; O'Keefe K; Spiegel R; Goodwin E; Keating S; Weetall M
    Front Oncol; 2022; 12():832816. PubMed ID: 35223511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.